Effects of Sodium-Glucose Co-transporter 2 Inhibitors on Hemoglobin Levels: A Meta-analysis of Randomized Controlled Trials

Background: This study aimed to explore the effects of sodium-glucose co-transporter 2 (SGLT2) on hemoglobin levels in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease. Methods: PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, the China National Knowledge I...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Wei, Yao, Li, Liu, Xiaodan, Xu, Tianhua, Tian, Binyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994761/
https://www.ncbi.nlm.nih.gov/pubmed/33776773
http://dx.doi.org/10.3389/fphar.2021.630820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994761/
https://www.ncbi.nlm.nih.gov/pubmed/33776773
http://dx.doi.org/10.3389/fphar.2021.630820

Ejemplares similares